Merck
Biotech

Merck and Moderna post phase 3 cancer vaccine data early

While the primary endpoint hit approached analysts’ best-case scenario, the result was tempered by weaker-than-expected data on a secondary endpoint.
Saudi Arabia takes actionable steps to build its biotech sector after 46 agreements in Riyadh

Saudi Arabia takes actionable steps to build its biotech sector

Graphic of a puzzle depicting both the US and Chinese flags with missing pieces bridging the two together

Treasury COINS rules add biotech, spares China licensing deals

Oct 22, 2026 11:36pm
From Scientific Hypothesis to Clinical Practice The Next Chapter for CLDN182

The next chapter of CLDN18.2-directed innovation

Brought to you by Astellas Pharma US
Schinecker

Roche CEO has ‘absolutely not’ changed view on Poseida buyout

Oct 22, 2026 4:16am
Aligning drug discovery around patient benefit from the outset Connecting human insights to better decisions

Aligning drug discovery around patient benefit from the outset: Connecting human insights to better decisions

Brought to you by IQVIA Laboratories
More News

Menarini gets Georgiamune preclinical cancer drug in $1B deal

Oct 22, 2026 10:50am

AbbVie posts phase 3 HS win but falls short of expectations

Oct 22, 2026 10:39am

Celltrion picks up another Kaigene antibody for up to $580.5M

Oct 22, 2026 10:22am

Rebranded NodThera plans IPO to fund NLRP3 inhibitor program

Oct 22, 2026 5:27am